Relationship among metabolic syndrome, C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and insulin resistance
Abstract Background It has been demonstrated that the polymorphism 385 C/A of FAAH (fatty acid amide hydrolase) was associated with obesity and metabolic disorders. Objective The aim of our study was to investigate the relationship of the polymorphism (cDNA 385 C- > A) of FAAH gene and insulin re...
Gespeichert in:
| Veröffentlicht in: | Journal of diabetes and its complications 2012-07, Vol.26 (4), p.328-332 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 332 |
|---|---|
| container_issue | 4 |
| container_start_page | 328 |
| container_title | Journal of diabetes and its complications |
| container_volume | 26 |
| creator | de Luis, D.A Aller, R Izaola, O Conde, R Sagrado, M. Gonzalez Primo, D Castro, M.J |
| description | Abstract Background It has been demonstrated that the polymorphism 385 C/A of FAAH (fatty acid amide hydrolase) was associated with obesity and metabolic disorders. Objective The aim of our study was to investigate the relationship of the polymorphism (cDNA 385 C- > A) of FAAH gene and insulin resistance in obese patients with and without metabolic syndrome. Design A population of 799 obese patients was analyzed in cross-sectional survey. A bioimpedance, blood pressure, serial assessment of nutritional intake with 3 days written food records and biochemical analysis were performed. Genotype of FAAH gene polymorphism was studied. Results Prevalence of metabolic syndrome (MS) with ATP III definition was 49.8% (398 patients) and 50.2% patients without MS (n = 401 patients). Prevalence of FAAH genotypes was similar in patients with metabolic syndrome (69.6% wild genotype and 30.4% mutant genotype) and without metabolic syndrome (66.6% wild genotype and 33.4% mutant genotype). In patients without metabolic syndrome, insulin and HOMA levels were higher in mutant genotype than wild type group. Conclusion The main finding is the lack of association of the FAAH genotypes with metabolic syndrome prevalence. Patients with mutant genotype group of FAAH gene and without metabolic syndrome have higher insulin and HOMA levels than wild type group. |
| doi_str_mv | 10.1016/j.jdiacomp.2012.04.002 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1026699810</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1056872712000700</els_id><sourcerecordid>2748229461</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-ff36869e36f8a1f6eee7896c19031b701d9be6fabad0ec8b8332a20d7ca9c3203</originalsourceid><addsrcrecordid>eNqFkl1rFDEYhQdRbK3-hRLwpoKz5mM3M7kRl8VaoSD4Ad6Fd5J3ulknyTSZFcaf4q81y7YKvfEqgTznJDnnrapzRheMMvlmt9hZByb6ccEp4wu6XFDKH1WnrG1EvZT0--OypytZtw1vTqpnOe8opXK1Yk-rE84lVZzJ0-r3ZxxgcjHkrRsJ-BhuiMcJujg4Q_IcbIoeX5ONWLVrMsZh9jGNW5c9iT2Ztkgw2GggBOhciM4SizcJrCs-GH7NHkkP0zQTMOUMvLNItnMxHSAjubhcr69eEQiWuJD3gwskYXZ5gmDwefWkhyHji7v1rPp2-f7r5qq-_vTh42Z9XZvlik113wvZSoVC9i2wXiJi0yppmKKCdQ1lVnUoe-jAUjRt1wrBgVPbGFBGcCrOqouj75ji7R7zpL3LBocBAsZ91oxyKZVq2QF9-QDdxX0K5XWFElI1gilVKHmkTIo5J-z1mJyHNBdIH9rTO33fnj60p-lSl_aK8PzOft95tH9l93UV4N0RwJLHT4dJZ-OwZGVdQjNpG93_73j7wMKU2J2B4QfOmP_9R-ei0V8OM3QYIcbL-DSUij_ziMVy</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1036973199</pqid></control><display><type>article</type><title>Relationship among metabolic syndrome, C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and insulin resistance</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><source>ProQuest Central UK/Ireland</source><creator>de Luis, D.A ; Aller, R ; Izaola, O ; Conde, R ; Sagrado, M. Gonzalez ; Primo, D ; Castro, M.J</creator><creatorcontrib>de Luis, D.A ; Aller, R ; Izaola, O ; Conde, R ; Sagrado, M. Gonzalez ; Primo, D ; Castro, M.J</creatorcontrib><description>Abstract Background It has been demonstrated that the polymorphism 385 C/A of FAAH (fatty acid amide hydrolase) was associated with obesity and metabolic disorders. Objective The aim of our study was to investigate the relationship of the polymorphism (cDNA 385 C- > A) of FAAH gene and insulin resistance in obese patients with and without metabolic syndrome. Design A population of 799 obese patients was analyzed in cross-sectional survey. A bioimpedance, blood pressure, serial assessment of nutritional intake with 3 days written food records and biochemical analysis were performed. Genotype of FAAH gene polymorphism was studied. Results Prevalence of metabolic syndrome (MS) with ATP III definition was 49.8% (398 patients) and 50.2% patients without MS (n = 401 patients). Prevalence of FAAH genotypes was similar in patients with metabolic syndrome (69.6% wild genotype and 30.4% mutant genotype) and without metabolic syndrome (66.6% wild genotype and 33.4% mutant genotype). In patients without metabolic syndrome, insulin and HOMA levels were higher in mutant genotype than wild type group. Conclusion The main finding is the lack of association of the FAAH genotypes with metabolic syndrome prevalence. Patients with mutant genotype group of FAAH gene and without metabolic syndrome have higher insulin and HOMA levels than wild type group.</description><identifier>ISSN: 1056-8727</identifier><identifier>EISSN: 1873-460X</identifier><identifier>DOI: 10.1016/j.jdiacomp.2012.04.002</identifier><identifier>PMID: 22609216</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Amidohydrolases - genetics ; ATP III ; Cardiovascular disease ; Cholesterol ; Comorbidity ; Cross-Sectional Studies ; Diabetes ; Endocrinology & Metabolism ; FAAH ; Female ; Genotype ; Homeostasis ; Humans ; Insulin - blood ; Insulin resistance ; Insulin Resistance - genetics ; Male ; Metabolic syndrome ; Metabolic Syndrome - blood ; Metabolic Syndrome - epidemiology ; Metabolic Syndrome - genetics ; Metabolism ; Middle Aged ; Obesity ; Obesity - blood ; Obesity - epidemiology ; Obesity - genetics ; Polymorphism, Genetic - genetics ; Prevalence</subject><ispartof>Journal of diabetes and its complications, 2012-07, Vol.26 (4), p.328-332</ispartof><rights>Elsevier Inc.</rights><rights>2012 Elsevier Inc.</rights><rights>Copyright © 2012 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-ff36869e36f8a1f6eee7896c19031b701d9be6fabad0ec8b8332a20d7ca9c3203</citedby><cites>FETCH-LOGICAL-c451t-ff36869e36f8a1f6eee7896c19031b701d9be6fabad0ec8b8332a20d7ca9c3203</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1036973199?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994,64384,64386,64388,72240</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22609216$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>de Luis, D.A</creatorcontrib><creatorcontrib>Aller, R</creatorcontrib><creatorcontrib>Izaola, O</creatorcontrib><creatorcontrib>Conde, R</creatorcontrib><creatorcontrib>Sagrado, M. Gonzalez</creatorcontrib><creatorcontrib>Primo, D</creatorcontrib><creatorcontrib>Castro, M.J</creatorcontrib><title>Relationship among metabolic syndrome, C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and insulin resistance</title><title>Journal of diabetes and its complications</title><addtitle>J Diabetes Complications</addtitle><description>Abstract Background It has been demonstrated that the polymorphism 385 C/A of FAAH (fatty acid amide hydrolase) was associated with obesity and metabolic disorders. Objective The aim of our study was to investigate the relationship of the polymorphism (cDNA 385 C- > A) of FAAH gene and insulin resistance in obese patients with and without metabolic syndrome. Design A population of 799 obese patients was analyzed in cross-sectional survey. A bioimpedance, blood pressure, serial assessment of nutritional intake with 3 days written food records and biochemical analysis were performed. Genotype of FAAH gene polymorphism was studied. Results Prevalence of metabolic syndrome (MS) with ATP III definition was 49.8% (398 patients) and 50.2% patients without MS (n = 401 patients). Prevalence of FAAH genotypes was similar in patients with metabolic syndrome (69.6% wild genotype and 30.4% mutant genotype) and without metabolic syndrome (66.6% wild genotype and 33.4% mutant genotype). In patients without metabolic syndrome, insulin and HOMA levels were higher in mutant genotype than wild type group. Conclusion The main finding is the lack of association of the FAAH genotypes with metabolic syndrome prevalence. Patients with mutant genotype group of FAAH gene and without metabolic syndrome have higher insulin and HOMA levels than wild type group.</description><subject>Adult</subject><subject>Amidohydrolases - genetics</subject><subject>ATP III</subject><subject>Cardiovascular disease</subject><subject>Cholesterol</subject><subject>Comorbidity</subject><subject>Cross-Sectional Studies</subject><subject>Diabetes</subject><subject>Endocrinology & Metabolism</subject><subject>FAAH</subject><subject>Female</subject><subject>Genotype</subject><subject>Homeostasis</subject><subject>Humans</subject><subject>Insulin - blood</subject><subject>Insulin resistance</subject><subject>Insulin Resistance - genetics</subject><subject>Male</subject><subject>Metabolic syndrome</subject><subject>Metabolic Syndrome - blood</subject><subject>Metabolic Syndrome - epidemiology</subject><subject>Metabolic Syndrome - genetics</subject><subject>Metabolism</subject><subject>Middle Aged</subject><subject>Obesity</subject><subject>Obesity - blood</subject><subject>Obesity - epidemiology</subject><subject>Obesity - genetics</subject><subject>Polymorphism, Genetic - genetics</subject><subject>Prevalence</subject><issn>1056-8727</issn><issn>1873-460X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkl1rFDEYhQdRbK3-hRLwpoKz5mM3M7kRl8VaoSD4Ad6Fd5J3ulknyTSZFcaf4q81y7YKvfEqgTznJDnnrapzRheMMvlmt9hZByb6ccEp4wu6XFDKH1WnrG1EvZT0--OypytZtw1vTqpnOe8opXK1Yk-rE84lVZzJ0-r3ZxxgcjHkrRsJ-BhuiMcJujg4Q_IcbIoeX5ONWLVrMsZh9jGNW5c9iT2Ztkgw2GggBOhciM4SizcJrCs-GH7NHkkP0zQTMOUMvLNItnMxHSAjubhcr69eEQiWuJD3gwskYXZ5gmDwefWkhyHji7v1rPp2-f7r5qq-_vTh42Z9XZvlik113wvZSoVC9i2wXiJi0yppmKKCdQ1lVnUoe-jAUjRt1wrBgVPbGFBGcCrOqouj75ji7R7zpL3LBocBAsZ91oxyKZVq2QF9-QDdxX0K5XWFElI1gilVKHmkTIo5J-z1mJyHNBdIH9rTO33fnj60p-lSl_aK8PzOft95tH9l93UV4N0RwJLHT4dJZ-OwZGVdQjNpG93_73j7wMKU2J2B4QfOmP_9R-ei0V8OM3QYIcbL-DSUij_ziMVy</recordid><startdate>20120701</startdate><enddate>20120701</enddate><creator>de Luis, D.A</creator><creator>Aller, R</creator><creator>Izaola, O</creator><creator>Conde, R</creator><creator>Sagrado, M. Gonzalez</creator><creator>Primo, D</creator><creator>Castro, M.J</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K6X</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20120701</creationdate><title>Relationship among metabolic syndrome, C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and insulin resistance</title><author>de Luis, D.A ; Aller, R ; Izaola, O ; Conde, R ; Sagrado, M. Gonzalez ; Primo, D ; Castro, M.J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-ff36869e36f8a1f6eee7896c19031b701d9be6fabad0ec8b8332a20d7ca9c3203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adult</topic><topic>Amidohydrolases - genetics</topic><topic>ATP III</topic><topic>Cardiovascular disease</topic><topic>Cholesterol</topic><topic>Comorbidity</topic><topic>Cross-Sectional Studies</topic><topic>Diabetes</topic><topic>Endocrinology & Metabolism</topic><topic>FAAH</topic><topic>Female</topic><topic>Genotype</topic><topic>Homeostasis</topic><topic>Humans</topic><topic>Insulin - blood</topic><topic>Insulin resistance</topic><topic>Insulin Resistance - genetics</topic><topic>Male</topic><topic>Metabolic syndrome</topic><topic>Metabolic Syndrome - blood</topic><topic>Metabolic Syndrome - epidemiology</topic><topic>Metabolic Syndrome - genetics</topic><topic>Metabolism</topic><topic>Middle Aged</topic><topic>Obesity</topic><topic>Obesity - blood</topic><topic>Obesity - epidemiology</topic><topic>Obesity - genetics</topic><topic>Polymorphism, Genetic - genetics</topic><topic>Prevalence</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Luis, D.A</creatorcontrib><creatorcontrib>Aller, R</creatorcontrib><creatorcontrib>Izaola, O</creatorcontrib><creatorcontrib>Conde, R</creatorcontrib><creatorcontrib>Sagrado, M. Gonzalez</creatorcontrib><creatorcontrib>Primo, D</creatorcontrib><creatorcontrib>Castro, M.J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>British Nursing Index</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of diabetes and its complications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Luis, D.A</au><au>Aller, R</au><au>Izaola, O</au><au>Conde, R</au><au>Sagrado, M. Gonzalez</au><au>Primo, D</au><au>Castro, M.J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Relationship among metabolic syndrome, C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and insulin resistance</atitle><jtitle>Journal of diabetes and its complications</jtitle><addtitle>J Diabetes Complications</addtitle><date>2012-07-01</date><risdate>2012</risdate><volume>26</volume><issue>4</issue><spage>328</spage><epage>332</epage><pages>328-332</pages><issn>1056-8727</issn><eissn>1873-460X</eissn><abstract>Abstract Background It has been demonstrated that the polymorphism 385 C/A of FAAH (fatty acid amide hydrolase) was associated with obesity and metabolic disorders. Objective The aim of our study was to investigate the relationship of the polymorphism (cDNA 385 C- > A) of FAAH gene and insulin resistance in obese patients with and without metabolic syndrome. Design A population of 799 obese patients was analyzed in cross-sectional survey. A bioimpedance, blood pressure, serial assessment of nutritional intake with 3 days written food records and biochemical analysis were performed. Genotype of FAAH gene polymorphism was studied. Results Prevalence of metabolic syndrome (MS) with ATP III definition was 49.8% (398 patients) and 50.2% patients without MS (n = 401 patients). Prevalence of FAAH genotypes was similar in patients with metabolic syndrome (69.6% wild genotype and 30.4% mutant genotype) and without metabolic syndrome (66.6% wild genotype and 33.4% mutant genotype). In patients without metabolic syndrome, insulin and HOMA levels were higher in mutant genotype than wild type group. Conclusion The main finding is the lack of association of the FAAH genotypes with metabolic syndrome prevalence. Patients with mutant genotype group of FAAH gene and without metabolic syndrome have higher insulin and HOMA levels than wild type group.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>22609216</pmid><doi>10.1016/j.jdiacomp.2012.04.002</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1056-8727 |
| ispartof | Journal of diabetes and its complications, 2012-07, Vol.26 (4), p.328-332 |
| issn | 1056-8727 1873-460X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1026699810 |
| source | MEDLINE; ScienceDirect Journals (5 years ago - present); ProQuest Central UK/Ireland |
| subjects | Adult Amidohydrolases - genetics ATP III Cardiovascular disease Cholesterol Comorbidity Cross-Sectional Studies Diabetes Endocrinology & Metabolism FAAH Female Genotype Homeostasis Humans Insulin - blood Insulin resistance Insulin Resistance - genetics Male Metabolic syndrome Metabolic Syndrome - blood Metabolic Syndrome - epidemiology Metabolic Syndrome - genetics Metabolism Middle Aged Obesity Obesity - blood Obesity - epidemiology Obesity - genetics Polymorphism, Genetic - genetics Prevalence |
| title | Relationship among metabolic syndrome, C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and insulin resistance |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T19%3A57%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Relationship%20among%20metabolic%20syndrome,%20C358A%20polymorphism%20of%20the%20endocannabinoid%20degrading%20enzyme%20fatty%20acid%20amide%20hydrolase%20(FAAH)%20and%20insulin%20resistance&rft.jtitle=Journal%20of%20diabetes%20and%20its%20complications&rft.au=de%20Luis,%20D.A&rft.date=2012-07-01&rft.volume=26&rft.issue=4&rft.spage=328&rft.epage=332&rft.pages=328-332&rft.issn=1056-8727&rft.eissn=1873-460X&rft_id=info:doi/10.1016/j.jdiacomp.2012.04.002&rft_dat=%3Cproquest_cross%3E2748229461%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1036973199&rft_id=info:pmid/22609216&rft_els_id=S1056872712000700&rfr_iscdi=true |